The company specializes in researching and developing new drugs for immune-oncology and targeted cancer therapy, as well as drugs for Alzheimer's dementia. Their goal is to discover promising molecule targets for first-in-class cancer treatment therapies. BiSiChem is at the forefront of the biotechnology industry, with a strong focus on advancing the field of drug discovery and development.